Back

Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction - A nationwide cohort study

1 May 2017 (09:12 - 09:18)
Organised by:
Congress Presentation Part of: Rapid Fire 4 - Therapy and management Chronic pulmonary hypertension HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Ola Vedin

AstraZeneca, Molndal (Sweden)

13 More presentations in this session

Presentation thumbnail
Physical activity measured with implanted devices predicts heart failure outcomes
Professor C. Linde (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Age and effect of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure.
Mrs M. Elming (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Use of mineralocorticoid receptor antagonists in a real-world population with heart failure and reduced ejection fraction: an analysis of 24,529 patients from the swedish heart failure registry
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulant use in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,719 patients from the swedish heart failure registry
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibition differentially reduces extracellular fluid volume relative to blood volume: a hypothesis for heart failure protection
Assistant Professor M. Hallow (Athens, GA, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 4 - Therapy and management

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 09:12 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources